CARRIE PONTE: Open Payments
NPI 1114460078 · RUMFORD, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 9 payments from 5 companies in 2025. Trend: 2023 $253 · 2024 $224 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $79 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $41 |
| Amgen Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: TREMFYA, EBGLYSS, OTEZLA, RINVOQ, DUPIXENT, SKYRIZI.
Industry payments across ME — which companies pay providers there.
